Atlanta Cancer Care - Stockbridge — Stockbridge, Georgia

Atlanta Cancer Care - Stockbridge is a clinical research site located in Stockbridge, Georgia, United States 30281.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Atlanta Cancer Care - Stockbridge has participated in 1 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atlanta Cancer Care - Stockbridge?

Atlanta Cancer Care - Stockbridge has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atlanta Cancer Care - Stockbridge conducted?

Atlanta Cancer Care - Stockbridge has 1 clinical trials on record. Their work covers HER2 Positive Breast Cancer.

Is Atlanta Cancer Care - Stockbridge accredited by Crixeo Health?

Atlanta Cancer Care - Stockbridge has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atlanta Cancer Care - Stockbridge?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.